Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti infectives. Galapagos approach is to develop drugs that stop or reverse a disease state using novel targets that are identified through a patent protected target discovery platform. Galapagos also provides access to its target and drug discovery platform through its services division, BioFocus and Argenta, which offers a full suite of target to drug discovery products and services to pharmaceutical and biotech companies.
Quote | Galapagos Genomics Ord (OTCMKTS:GLPGF)
Last: | $22.60 |
---|---|
Change Percent: | 0.0% |
Open: | $22.6 |
Close: | $22.60 |
High: | $22.6 |
Low: | $22.6 |
Volume: | 12 |
Last Trade Date Time: | 06/21/2024 03:00:00 am |
News | Galapagos Genomics Ord (OTCMKTS:GLPGF)
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual Euro...
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos’ decentralized manufacturing platform in patients with head & neck cancer Uza-cel has shown enc...
Message Board Posts | Galapagos Genomics Ord (OTCMKTS:GLPGF)
Subject | By | Source | When |
---|---|---|---|
Galapagos Genomics NV changed to Galapagos NV: | Renee | investorshub | 10/02/2015 8:59:30 PM |
Galapagos acquires structure-based drug discovery from Sareum | surf1944 | investorshub | 09/05/2008 1:13:36 AM |
UCB transfers UK-based medicinal chemistry program to BioFocus DPI | surf1944 | investorshub | 08/18/2008 4:01:00 PM |
Galapagos announces milestone payment of EUR 0.8 million | surf1944 | investorshub | 07/10/2008 2:40:55 PM |
Galapagos signs research agreement with UCL | surf1944 | investorshub | 06/03/2008 1:08:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Galapagos Genomics Ord Company Name:
GLPGF Stock Symbol:
OTCMKTS Market:
Galapagos Genomics Ord Website:
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual Euro...
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos’ decentralized manufacturing platform in patients with head & neck cancer Uza-cel has shown enc...
BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centers Collaboration enables rapid deployment of Galapagos' decentralized CAR-T platform across the U.S., improving patient access ...